These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 17599323)
1. Reassessing the cutoff level for poliovirus antibody in patients after successful chemotherapy for leukemia or hematopoietic stem cell transplantation. Arya SC; Agarwal N Clin Infect Dis; 2007 Aug; 45(3):397; author reply 398-9. PubMed ID: 17599323 [No Abstract] [Full Text] [Related]
2. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia. Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296 [TBL] [Abstract][Full Text] [Related]
3. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome. Gil L; Styczynski J; Komarnicki M Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001 [TBL] [Abstract][Full Text] [Related]
4. Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation. Chotsampancharoen T; Gan K; Kasow KA; Barfield RC; Hale GA; Leung W Pediatr Transplant; 2009 May; 13(3):348-52. PubMed ID: 18518909 [TBL] [Abstract][Full Text] [Related]
5. [Recent progress in the field of hematopoietic stem cell transplantation for leukemia]. Kobayashi T; Akiyama H Gan To Kagaku Ryoho; 2009 Mar; 36(3):351-6. PubMed ID: 19295257 [TBL] [Abstract][Full Text] [Related]
6. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission. Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V; Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352 [TBL] [Abstract][Full Text] [Related]
7. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation]. Fu YW; Wu DP; Sun AN; Feng YF; Chang WR; Zhu ZL; Zhu P Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):312-7. PubMed ID: 17877159 [TBL] [Abstract][Full Text] [Related]
8. CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin. Dong L; Wu T; Zhang MJ; Gao ZY; Lu DP Biol Blood Marrow Transplant; 2007 Dec; 13(12):1515-24. PubMed ID: 18022582 [TBL] [Abstract][Full Text] [Related]
9. From 'megadose' haploidentical hematopoietic stem cell transplants in acute leukemia to tolerance induction in organ transplantation. Reisner Y; Martelli MF Blood Cells Mol Dis; 2008; 40(1):1-7. PubMed ID: 17981059 [TBL] [Abstract][Full Text] [Related]
10. [Donor peripheral stem cells infusion for the treatment of failure of platelet recovery after allogeneic hematopoietic stem cell transplantation]. Chen Y; Xu LP; Liu DH; Chen YH; Han W; Shi HX; Zhang XH; Wang JZ; Chen H; Liu KY; Huang XJ; Lu DP Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):964-6. PubMed ID: 17650420 [TBL] [Abstract][Full Text] [Related]
11. Controversies of and unique issues in hematopoietic cell transplantation for infant leukemia. Hunger SP; Loh KM; Baker KS; Schultz KR Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):79-83. PubMed ID: 19147083 [TBL] [Abstract][Full Text] [Related]
12. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G; Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401 [TBL] [Abstract][Full Text] [Related]
13. Outcome of 93 patients with relapse or progression following allogeneic hematopoietic cell transplantation. Kurosawa S; Fukuda T; Tajima K; Saito B; Fuji S; Yokoyama H; Kim SW; Mori S; Tanosaki R; Heike Y; Takaue Y Am J Hematol; 2009 Dec; 84(12):815-20. PubMed ID: 19899134 [TBL] [Abstract][Full Text] [Related]
14. [Prevention and treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation for acute leukemias]. Da WM; Wu T; Lu DP Zhonghua Xue Ye Xue Za Zhi; 2007 Dec; 28(12):793-4. PubMed ID: 18476587 [No Abstract] [Full Text] [Related]
15. [Physiopathology and possible clinical use of hematopoietic stem cells. Recent advances]. Testa U Recenti Prog Med; 2009 Mar; 100(3):144-55. PubMed ID: 19475843 [TBL] [Abstract][Full Text] [Related]
16. Vaccinations in children treated with standard-dose cancer therapy or hematopoietic stem cell transplantation. Patel SR; Chisholm JC; Heath PT Pediatr Clin North Am; 2008 Feb; 55(1):169-86, xi. PubMed ID: 18242320 [TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis. Schetelig J; van Biezen A; Brand R; Caballero D; Martino R; Itala M; García-Marco JA; Volin L; Schmitz N; Schwerdtfeger R; Ganser A; Onida F; Mohr B; Stilgenbauer S; Bornhäuser M; de Witte T; Dreger P J Clin Oncol; 2008 Nov; 26(31):5094-100. PubMed ID: 18711173 [TBL] [Abstract][Full Text] [Related]
18. Advance in hematopoietic stem cells transplantation for leukemia. Huang XJ Chin Med J (Engl); 2008 Sep; 121(18):1763-5. PubMed ID: 19080353 [No Abstract] [Full Text] [Related]
19. Autologous hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: still not out of fashion. Doubek M; Folber F; Koristek Z; Brychtova Y; Krejci M; Tomiska M; Navratil M; Mikulasova P; Mayer J Ann Hematol; 2009 Sep; 88(9):881-7. PubMed ID: 19172272 [TBL] [Abstract][Full Text] [Related]
20. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation. You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]